| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4028703 | Ophthalmology | 2008 | 10 Pages |
Abstract
The Artisan/Verisyse phakic IOL provides excellent refractive outcomes; endothelial cell loss within a mean of 5.0% over 3 years, or 1.8% per year; and few complications.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
R. Doyle MD, PhD, Maurice E. MD, Robert K. MD, Kerry K. MD, Peter N. MD, Vance M. MD, U.S. Verisyse Study Group U.S. Verisyse Study Group,